» Articles » PMID: 38001748

The Promise of Piperine in Cancer Chemoprevention

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2023 Nov 25
PMID 38001748
Authors
Affiliations
Soon will be listed here.
Abstract

Cancer, characterized by the unregulated growth and dissemination of malignantly transformed cells, presents a significant global health challenge. The multistage process of cancer development involves intricate biochemical and genetic alterations within target cells. Cancer chemoprevention has emerged as a vital strategy to address this complex issue to mitigate cancer's impact on healthcare systems. This approach leverages pharmacologically active agents to block, suppress, prevent, or reverse invasive cancer development. Among these agents, piperine, an active alkaloid with a wide range of therapeutic properties, including antioxidant, anti-inflammatory, and immunomodulatory effects, has garnered attention for its potential in cancer prevention and treatment. This comprehensive review explores piperine's multifaceted role in inhibiting the molecular events and signaling pathways associated with various stages of cancer development, shedding light on its promising prospects as a versatile tool in cancer chemoprevention. Furthermore, the review will also delve into how piperine enhances the effectiveness of conventional treatments such as UV-phototherapy and TRAIL-based therapy, potentially synergizing with existing therapeutic modalities to provide more robust cancer management strategies. Finally, a crucial perspective of the long-term safety and potential side effects of piperine-based therapies and the need for clinical trials is also discussed.

Citing Articles

Gamma-Tocopherol: A Comprehensive Review of Its Antioxidant, Anti-Inflammatory, and Anticancer Properties.

Es-Sai B, Wahnou H, Benayad S, Rabbaa S, Laaziouez Y, El Kebbaj R Molecules. 2025; 30(3).

PMID: 39942758 PMC: 11821177. DOI: 10.3390/molecules30030653.


Harnessing the anticancer potential of Piper nigrum: a synergistic approach to chemotherapy enhancement and reduced side effects.

Wiraswati H, Maruf I, Hidayati N, Ramadhanti J, Calina D, Sharifi-Rad J Discov Oncol. 2025; 16(1):10.

PMID: 39760812 PMC: 11704108. DOI: 10.1007/s12672-024-01716-4.


Promising and challenging phytochemicals targeting LC3 mediated autophagy signaling in cancer therapy.

Rajendran P, Renu K, Ali E, Genena M, Veeraraghavan V, Sekar R Immun Inflamm Dis. 2024; 12(10):e70041.

PMID: 39436197 PMC: 11494898. DOI: 10.1002/iid3.70041.


Nature's weapons: Bioactive compounds as anti-cancer agents.

Auti A, Tathode M, Marino M, Vitiello A, Ballini A, Miele F AIMS Public Health. 2024; 11(3):747-772.

PMID: 39416904 PMC: 11474324. DOI: 10.3934/publichealth.2024038.


Natural Products and Altered Metabolism in Cancer: Therapeutic Targets and Mechanisms of Action.

Talib W, Baban M, Bulbul M, Al-Zaidaneen E, Allan A, Al-Rousan E Int J Mol Sci. 2024; 25(17).

PMID: 39273552 PMC: 11394730. DOI: 10.3390/ijms25179593.


References
1.
Li Y, Li K, Hu Y, Xu B, Zhao J . Piperine mediates LPS induced inflammatory and catabolic effects in rat intervertebral disc. Int J Clin Exp Pathol. 2015; 8(6):6203-13. PMC: 4525831. View

2.
Greenshields A, Doucette C, Sutton K, Madera L, Annan H, Yaffe P . Piperine inhibits the growth and motility of triple-negative breast cancer cells. Cancer Lett. 2014; 357(1):129-140. DOI: 10.1016/j.canlet.2014.11.017. View

3.
Mittal R, Gupta R . In vitro antioxidant activity of piperine. Methods Find Exp Clin Pharmacol. 2000; 22(5):271-4. DOI: 10.1358/mf.2000.22.5.796644. View

4.
Tobelem G . Tumor angiogenesis. Nouv Rev Fr Hematol (1978). 1990; 32(6):405-6. View

5.
Verma A, Kushwaha H, Srivastava A, Srivastava S, Jamal N, Srivastava K . Piperine attenuates UV-R induced cell damage in human keratinocytes via NF-kB, Bax/Bcl-2 pathway: An application for photoprotection. J Photochem Photobiol B. 2017; 172:139-148. DOI: 10.1016/j.jphotobiol.2017.05.018. View